<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9</volume><submitter>Chen L</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Prostate cancer (PCa) is characterized by significant heterogeneity. Thus, novel prognostic indicators are required to improve prognosis and treatment.&lt;h4>Methods&lt;/h4>Cysteine rich secretory protein 3 (CRISP3) and serine peptidase inhibitor Kazal type 1 (SPINK1) levels in expressed prostatic secretion (EPS)-urine collected during digital rectal examination of 496 patients histologically diagnosed with PCa were detected &lt;i>via&lt;/i> enzyme-linked immunosorbent assay. A combined CRISP3 and SPINK1 prognostic grade (CSPG) was defined using cut-off values from receiver operating characteristic curves. Log-rank Kaplan-Meier survival curves investigated differences in prognosis between groups. Univariate and multivariate Cox analyses investigated the CSPG relationship with bioche</pubmed_abstract><journal>Frontiers in medicine</journal><pagination>832415</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8891445</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A Combined CRISP3 and SPINK1 Prognostic Grade in EPS-Urine and Establishment of Models to Predict Prognosis of Patients With Prostate Cancer.</pubmed_title><pmcid>PMC8891445</pmcid><pubmed_authors>Zhang E</pubmed_authors><pubmed_authors>Guan J</pubmed_authors><pubmed_authors>Chen Z</pubmed_authors><pubmed_authors>He J</pubmed_authors><pubmed_authors>Chen L</pubmed_authors><pubmed_authors>Yin B</pubmed_authors><pubmed_authors>Zhang M</pubmed_authors><pubmed_authors>Ye J</pubmed_authors><pubmed_authors>Liu W</pubmed_authors><pubmed_authors>Song Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Combined CRISP3 and SPINK1 Prognostic Grade in EPS-Urine and Establishment of Models to Predict Prognosis of Patients With Prostate Cancer.</name><description>&lt;h4>Background&lt;/h4>Prostate cancer (PCa) is characterized by significant heterogeneity. Thus, novel prognostic indicators are required to improve prognosis and treatment.&lt;h4>Methods&lt;/h4>Cysteine rich secretory protein 3 (CRISP3) and serine peptidase inhibitor Kazal type 1 (SPINK1) levels in expressed prostatic secretion (EPS)-urine collected during digital rectal examination of 496 patients histologically diagnosed with PCa were detected &lt;i>via&lt;/i> enzyme-linked immunosorbent assay. A combined CRISP3 and SPINK1 prognostic grade (CSPG) was defined using cut-off values from receiver operating characteristic curves. Log-rank Kaplan-Meier survival curves investigated differences in prognosis between groups. Univariate and multivariate Cox analyses investigated the CSPG relationship with bioche</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-04T09:00:41.635Z</modification><creation>2025-04-04T09:00:41.635Z</creation></dates><accession>S-EPMC8891445</accession><cross_references><pubmed>35252264</pubmed><doi>10.3389/fmed.2022.832415</doi></cross_references></HashMap>